TearLab (TEAR) stock price, revenue, and financials

TearLab market cap is $1.7 m, and annual revenue was $25 m in FY 2018

$1.7 M

TEAR Mkt cap, 08-Oct-2018

$5.9 M

TearLab Revenue Q2, 2019
TearLab Gross profit (Q2, 2019)3.8 M
TearLab Gross profit margin (Q2, 2019), %65.1%
TearLab EBIT (Q2, 2019)232 K
TearLab Cash, 30-Jun-20199.2 M
TearLab EV27.3 M

TearLab Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

14.6m19.7m25.2m28.0m27.1m25.0m

Revenue growth, %

35%28%11%

Cost of goods sold

8.1m8.8m10.8m10.2m11.0m

Gross profit

6.5m10.9m14.3m17.8m16.1m

Gross profit Margin, %

44%55%57%64%59%

Sales and marketing expense

13.0m19.3m14.4m12.3m3.3m

General and administrative expense

8.9m14.9m11.1m8.8m6.2m

Operating expense total

24.3m44.1m31.7m25.8m13.1m

Depreciation and amortization

1.5m1.1m

EBIT

(17.8m)(25.0m)(31.5m)(16.0m)(11.8m)2.5m

EBIT margin, %

(121%)(127%)(125%)(57%)(43%)10%

Interest expense

4.0m4.3m4.7m

Interest income

35.0k28.0k2.0m

Net Income

(29.0m)(23.7m)(33.2m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

4.2m4.2m5.0m5.2m5.4m6.3m6.6m6.8m6.9m7.2m6.7m7.0m6.5m6.4m6.4m6.2m5.7m5.9m

Cost of goods sold

2.3m2.2m2.5m2.7m2.4m2.8m2.8m2.5m2.5m2.6m2.7m3.0m1.8m2.4m2.2m1.9m2.0m

Gross profit

1.9m2.0m2.5m2.5m3.0m3.5m3.8m4.2m4.4m4.7m4.3m3.5m4.6m4.1m4.0m3.8m3.8m

Gross profit Margin, %

46%48%51%48%56%56%57%62%64%65%62%54%72%63%65%66%65%

Sales and marketing expense

3.3m3.9m3.8m4.1m5.3m5.1m4.6m4.6m3.4m3.1m3.3m3.3m2.7m1.0m959.0k759.0k875.0k995.0k

General and administrative expense

1.9m3.1m3.6m3.5m3.6m3.7m4.1m3.9m3.0m2.6m2.2m2.3m2.3m2.0m1.3m1.3m1.8m1.5m

Operating expense total

5.8m7.9m8.4m8.6m13.5m14.0m14.2m10.0m7.3m7.1m7.1m6.7m5.8m4.1m3.3m2.8m3.6m3.5m

Depreciation and amortization

303.0k395.0k382.0k382.0k304.0k382.0k359.0k

EBIT

(3.8m)(5.9m)(5.9m)(6.1m)(8.1m)(7.7m)(7.5m)(6.3m)(3.4m)(2.9m)(3.4m)(2.8m)(2.7m)217.0k498.0k998.0k7.0k232.0k

EBIT margin, %

(91%)(141%)(118%)(117%)(149%)(121%)(114%)(94%)(49%)(41%)(51%)(40%)(42%)3%8%16%0%4%

Interest income

11.0k7.0k9.0k6.0k140.0k488.0k502.0k883.0k1.0m1.0m1.0m1.0m1.1m1.1m1.1m1.2m1.4m1.4m

TearLab Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

37.8m16.3m13.8m15.5m7.3m8.5m

Accounts Receivable

3.5m2.5m3.0m2.3m1.5m1.2m

Inventories

885.0k4.0m3.2m2.0m2.0m

Current Assets

42.9m22.7m21.6m22.2m11.5m12.3m

PP&E

3.4m5.4m2.7m2.0m

Total Assets

50.0m31.0m28.4m26.6m14.3m14.5m

Accounts Payable

631.0k2.2m2.3m1.9m1.7m681.0k

Short-term debt

Current Liabilities

8.6m6.4m7.5m5.9m4.6m3.1m

Long-term debt

24.9m28.3m32.0m

Total Debt

24.9m28.3m32.0m

Total Liabilities

32.3m32.3m32.9m35.2m

Additional Paid-in Capital

477.2m483.9m488.5m506.9m510.2m510.4m

Retained Earnings

(435.8m)(459.6m)(492.8m)(512.7m)(528.8m)(531.1m)

Total Equity

41.4m24.4m(4.2m)(5.7m)(18.6m)(20.7m)

Debt to Equity Ratio

-1.5 x

Debt to Assets Ratio

2 x

Financial Leverage

1.2 x1.3 x-6.7 x-4.7 x-0.8 x-0.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

42.0m32.0m25.6m20.7m23.3m15.9m10.6m7.2m20.1m17.5m13.0m10.2m7.7m7.4m6.4m8.2m8.9m9.2m

Accounts Receivable

3.4m3.1m3.0m3.1m2.3m2.2m2.4m3.0m2.3m2.4m2.3m2.1m1.7m1.5m1.3m1.3m1.1m1.1m

Inventories

959.0k1.2m2.3m3.5m3.2m3.8m4.0m3.6m3.3m3.4m3.3m2.9m2.6m1.7m1.9m1.8m2.2m2.8m

Current Assets

46.8m36.9m31.4m28.1m29.8m22.7m17.9m15.1m26.8m24.2m19.8m16.3m12.7m11.2m9.9m11.7m12.8m13.5m

PP&E

4.0m4.4m5.1m5.6m5.2m5.0m4.7m3.9m3.7m3.4m2.5m2.2m1.9m1.8m1.6m

Total Assets

53.5m45.8m40.3m36.6m37.6m30.9m26.2m21.5m32.5m29.5m24.0m20.2m16.5m13.7m12.3m13.8m15.5m15.9m

Accounts Payable

905.0k1.8m667.0k1.8m2.5m1.9m3.1m3.0m2.3m1.9m2.7m3.0m1.9m1.1m459.0k1.1m1.3m1.4m

Short-term debt

3.6m7.2m11.2m8.0m16.5m

Current Liabilities

12.6m6.5m5.2m6.1m5.5m5.3m7.5m6.7m5.4m5.2m6.9m6.3m5.8m7.4m10.0m14.4m11.4m20.2m

Long-term debt

14.6m14.8m15.0m25.2m25.5m26.0m26.9m27.4m27.8m25.8m22.3m19.5m25.4m18.3m

Total Debt

14.6m14.8m15.0m25.2m25.5m26.0m26.9m27.4m27.8m29.4m29.6m30.7m33.4m34.8m

Total Liabilities

20.1m20.1m22.5m31.9m30.9m31.2m33.8m33.7m33.7m33.2m32.3m33.9m37.5m39.1m

Additional Paid-in Capital

472.6m480.7m481.8m482.8m485.0m486.3m487.3m489.6m503.7m504.7m507.3m507.5m507.7m510.2m510.3m510.3m510.4m510.4m

Retained Earnings

(431.7m)(441.4m)(446.8m)(452.6m)(467.7m)(475.8m)(483.9m)(500.0m)(504.4m)(508.4m)(517.1m)(521.0m)(524.8m)(529.7m)(530.4m)(530.5m)(532.4m)(533.6m)

Total Equity

10.5m3.5m(10.4m)1.6m(1.7m)(9.8m)(13.5m)(17.2m)(19.4m)(20.0m)(20.2m)(22.0m)(23.1m)

Debt to Equity Ratio

1.4 x4.3 x-2.4 x15.6 x-15.1 x-2.7 x-2 x-1.5 x-1.5 x-1.5 x

Debt to Assets Ratio

0.5 x0.6 x1.2 x0.8 x0.9 x1.1 x1.4 x2.1 x2.4 x2.2 x

Financial Leverage

2.9 x7.5 x-2.1 x19.9 x-17.1 x-2.4 x-1.5 x-1 x-0.7 x-0.6 x-0.7 x-0.7 x-0.7 x

TearLab Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(33.2m)(19.9m)(16.1m)(2.3m)

Depreciation and Amortization

1.5m1.1m

Accounts Receivable

742.0k744.0k350.0k

Inventories

780.0k1.1m11.0k

Accounts Payable

(335.0k)(138.0k)(1.0m)

Cash From Operating Activities

22.3m(21.4m)(2.5m)

Cash From Investing Activities

(2.9m)(3.4m)(1.4m)(989.0k)(461.0k)

Cash From Financing Activities

38.5m548.0k24.6m15.6m2.4m

Interest Paid

2.3m2.4m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(11.6m)(15.6m)(4.4m)(8.3m)(12.1m)(883.0k)(1.5m)(1.7m)(1.3m)(2.5m)

Depreciation and Amortization

395.0k382.0k382.0k382.0k382.0k304.0k382.0k359.0k

Accounts Receivable

3.0m3.1m2.3m2.2m2.4m(5.0k)763.0k614.0k13.0k152.0k624.0k84.0k263.0k217.0k88.0k63.0k

Inventories

2.3m3.5m3.2m3.8m4.0m338.0k665.0k568.0k(131.0k)313.0k603.0k314.0k143.0k245.0k(220.0k)(845.0k)

Accounts Payable

667.0k1.8m2.5m1.9m3.1m721.0k2.3m(328.0k)889.0k1.1m51.0k(647.0k)(1.3m)(666.0k)638.0k744.0k

Cash From Operating Activities

398.0k742.0k

Cash From Investing Activities

(844.0k)(1.2m)(223.0k)(570.0k)(744.0k)(73.0k)(119.0k)(129.0k)(11.0k)(42.0k)

Cash From Financing Activities

15.5m15.6m32.0k32.0k9.0k

Interest Paid

571.0k1.2m1.2m

TearLab Ratios

USDY, 2019

EV/EBIT

117.7 x

EV/CFO

36.8 x

Financial Leverage

-0.7 x

TearLab Employee Rating

2.812 votes
Culture & Values
3.1
Work/Life Balance
2.8
Senior Management
2.9
Salary & Benefits
3.0
Career Opportunities
2.6
Source